Home » Clinical Trials » Inherited retinal dystrophy » NCT06162585
NCT06162585

Long Term Follow-up for Subjects Who Previously Participated in the NTXMCO-002 RESTORE Study

Study Summary

This study will be conducted following Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) guidelines. Eligible subjects will be consented to return for scheduled study visits for this study following their completion in study NTXMCO-002 (RESTORE). They will not receive a second treatment with MCO-010 (or a repeated sham injection) in this study

Want to learn more about this trial?

Request More Info

Interventions

Gene Therapy product-MCO-010BIOLOGICAL
Safety evaluation to monitor long term effects of previously injected MCO-010 in RP patients

Study Locations

FacilityCityStateCountry
Nanoscope Clinical SiteBeverly HillsCaliforniaUnited States
Nanoscope Clinical SitePensacolaFloridaUnited States
Nanoscope Clinical SiteFargoNorth DakotaUnited States
Nanoscope Clinical SiteHoustonTexasUnited States
Nanoscope Clinical SiteMcAllenTexasUnited States
Nanoscope Clinical SiteAreciboPuerto Rico

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026